Thomas Perone left the role of General Counsel, Chief Compliance Officer and Corporate Secretary at Ovid Therapeutics on June 28, 2024, according to an SEC filing.
| Name | Thomas Perone |
|---|---|
| Role | General Counsel, Chief Compliance Officer and Corporate Secretary |
| Company | Ovid Therapeutics |
| Industry | Biotechnology |
| Location | New York, NY |
| Move | Departure |
| Date | June 28, 2024 |
| Source | an SEC filing |
Ovid Therapeutics disclosed that, in connection with a workforce reduction, Thomas Perone would cease serving as General Counsel, Chief Compliance Officer and Corporate Secretary as of the separation date. (Source: an SEC filing.)
Other general counsel moves in June 2024
- William J. Tennis Steps Down as Executive Vice President, General Counsel and Corporate Secretary of DiamondRock Hospitality (June 30, 2024)
- Robert Villaseñor Named Chief Legal and Compliance officer of Coinme (June 29, 2024)
- Rick Sinkfield Named Chief Legal Officer of ETS (June 29, 2024)
- Caryn K. Groce Named Acting General Counsel of Paramount Global (June 28, 2024)
- Christa A. D’Alimonte Steps Down as Executive Vice President, General Counsel and Secretary of Paramount Global (June 28, 2024)
- Kaliste Saloom Named General Counsel and Corporate Secretary of Mawson Infrastructure Group (June 28, 2024)
- Curtis Tao Named US General Counsel of HSBC (June 27, 2024)
- Antony Klapper Named General Counsel of Volkswagen Group of America (June 27, 2024)
Planning your own next move?
- Chief Compliance Officer jobs
- General Counsel and Chief Legal Officer jobs
- Deputy General Counsel jobs
- Biotech Counsel Jobs
Read our guide to becoming a general counsel and the in-house counsel salaries guide.
Browse every appointment in the General Counsel Directory.
Source: an SEC filing. InhouseBlog summarizes publicly reported general counsel moves and links to the original report.
Does this information need updating? Email us at info@inhouseblog.com.